Alonimid

This classification denotes a sedative and hypnotic with the molecular formula C14H13NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 14144823D4, chemically known as 1,2,3,4-tetrahydronaphthalin-1-spiro-3-piperidin-4,2,6-dion but generally known as alonimid, which bears US NIH Compound Identifier 17928. European Medicines Agency schedules Alonimid in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05356MIG. The term ALONIMID is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 26, No. 10 1972, List 12). ALONIMID is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule alonimid under HS 29251995 and SITC 51482. As of Q4 2014, ALONIMID remains the US FDA Preferred Term for this commodity. Alonimid bears US NLM identifiers UMLS ID C2828217 and NCI Concept Code C87203. SMILES: O=C1NC(=O)CCC21CCC(=O)C1C2CCCC1.